These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33976642)

  • 1. Adjuvant Treatment of the Salivary Duct Carcinoma with Her2 Overexpression.
    Berendika J; Jungić S; Tubić B; Malčić Kecman G; Rakita I; Gojković Z; Vještica M; Nikić G; Babić B
    Case Rep Oncol; 2021; 14(1):610-615. PubMed ID: 33976642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.
    Al-Qahtani KH; Tunio MA; Bayoumi Y; Gurusamy VM; Bahamdain FA; Fatani H
    J Otolaryngol Head Neck Surg; 2016 May; 45(1):32. PubMed ID: 27184361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary duct carcinoma of the parotid gland: A case report and review of the literature.
    Xie S; Yang H; Bredell M; Shen S; Yang H; Jin L; Zhang S
    Oncol Lett; 2015 Jan; 9(1):371-374. PubMed ID: 25435994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab.
    Corrêa TS; Matos GDR; Segura M; Dos Anjos CH
    Case Rep Oncol; 2018; 11(2):252-257. PubMed ID: 29867432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary Duct Carcinoma: Case Reports and Brief Review of the Literature.
    Kantamani D; Bandaru SS; Miatech JL; Stagg MP
    Case Rep Oncol Med; 2021; 2021():2672772. PubMed ID: 34671494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary duct carcinoma of the parotid gland.
    Mlika M; Kourda N; Zidi Y; Aloui R; Zneidi N; Rammeh S; Zermani R; Jilani SB
    J Oral Maxillofac Pathol; 2012 Jan; 16(1):134-6. PubMed ID: 22434951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parotid salivary duct carcinoma: a single institution's 20-year experience.
    Stodulski D; Mikaszewski B; Majewska H; Kuczkowski J
    Eur Arch Otorhinolaryngol; 2019 Jul; 276(7):2031-2038. PubMed ID: 31062093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary duct carcinoma responding to trastuzumab-based therapy: case report and review of the literature.
    Krishnamurthy J; Krishnamurty DM; Baker JJ; Zhen W; Lydiatt D; Ganti AK
    Head Neck; 2013 Dec; 35(12):E372-5. PubMed ID: 23765450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance.
    Nagao T; Gaffey TA; Visscher DW; Kay PA; Minato H; Serizawa H; Lewis JE
    Am J Surg Pathol; 2004 Mar; 28(3):319-26. PubMed ID: 15104294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination Chemohormonal Therapy in Metastatic Salivary Duct Carcinoma.
    Jeong ISD; Moyers J; Thung I; Thinn MM
    Am J Case Rep; 2020 Jun; 21():e925181. PubMed ID: 32601266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow metastases in salivary duct carcinoma of the parotid gland.
    Asarkar A; Takalkar A; Dhawan M; Nathan CAO
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful multimodal treatment of intraoral salivary duct carcinoma in a patient with multiple lymph node metastases: a case report.
    Imaue S; Tomihara K; Hamashima T; Tomizawa G; Nomura K; Sasahara M; Noguchi M
    World J Surg Oncol; 2017 Jan; 15(1):18. PubMed ID: 28073374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER2/neu negative salivary duct carcinoma of parotid: A case with forty months recurrence free follow up.
    Gokavarapu S; Fonseca D; Puthamakula S; Reddy BP; Reddy BS; Murthy S
    Int J Surg Case Rep; 2015; 8C():22-4. PubMed ID: 25603487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy.
    Nabili V; Tan JW; Bhuta S; Sercarz JA; Head CS
    Head Neck; 2007 Oct; 29(10):907-12. PubMed ID: 17563907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic Salivary Duct Carcinoma with ERBB2 Amplification and Sequential Response to Ado-Trastuzumab Emtansine and Neratinib: A Case Report.
    Asper N; Roth KS; Hany TF; Salzberg SP; Tinguely M; Kadvany Y; Trojan A
    Case Rep Oncol; 2023; 16(1):1500-1507. PubMed ID: 38033416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive micropapillary salivary duct carcinoma mixed with mucin-rich salivary duct carcinoma in minor salivary gland: a rare case report.
    Tomihara K; Miwa S; Takazakura T; Kamisaki Y; Noguchi M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jun; 121(6):e162-7. PubMed ID: 26725719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary duct carcinoma--a highly aggressive salivary gland tumor with HER-2/neu oncoprotein overexpression.
    Skálová A; Stárek ; Kucerová V; Szépe P; Plank L
    Pathol Res Pract; 2001; 197(9):621-6. PubMed ID: 11569926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low grade salivary duct carcinoma. A distinctive variant with a low grade histology and a predominant intraductal growth pattern.
    Delgado R; Klimstra D; Albores-Saavedra J
    Cancer; 1996 Sep; 78(5):958-67. PubMed ID: 8780532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive diagnosis and treatment of ductal carcinoma of the submandibular gland: case report and literature review.
    Liu F; Fan L; Lu L; Guo H; Nan J; Han F
    Int J Clin Exp Pathol; 2023; 16(3):67-75. PubMed ID: 37033394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary duct carcinoma in the mandible: a case report.
    Kikuchi Y; Hirota M; Iwai T; Aoki S; Chikumaru H; Kawabe R; Matsui Y
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e41-6. PubMed ID: 17321438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.